Viral driven Lymphoma
Speaking in session III of iwNHL 2018, Ruth Jarrett, MD, PhD, Mark Roschewski, MD, Richard Little, MD, and Catherine Bollard, MD, discuss risk factors, clinical aspects and treatment of virus-driven lymphomas.
University of Glasgow, Glasgow, Scotland
Ruth Jarret, MD, PhD, from University of Glasgow, Glasgow, Scotland speaks on the risk factors for EBV-associated lymphomas.
National Cancer Institute, Bethesda, MD
Mark Roschewski, MD, from National Cancer Institute, Bethesda, MD, talks about EBV-associated lymphoproliferative disorders.
National Cancer Institute, Bethesda, MD
Richard Little, MD, from National Cancer Institute, Bethesda, MD, discusses the clinical aspects and management of AIDS-related lymphoma.
Children’s National Medical Center, Washington, DC
Catherine Bollard, MD, Children’s National Medical Center, Washington, DC, gives a talk on the use of T-cells for treating lymphomas driven by viruses.